AI News

.:
  •  
    •  
      •  
  •  
  •  
    •  
    •  
  •  
  •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
  •  
loader

Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

MedCity News - (Sunday February 19, 2023)
Frequent Updates/ MedCity News

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…

Bonus Features – February 19, 2023 – 80% of orgs collect SDOH data but struggle to make use of it, 2 in 3 cybersecurity pros say their orgs underestimate threats, and more

Healthcare IT Today - (Sunday February 19, 2023)
Daily Reads/ Healthcare IT Today

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
Surveys
A survey of 2,600 AHIMA members found that about 80% of healthcare organizations are collecting social determinants of health data. The bad news: Organizations face multiple challenges…

Weekly Roundup – February 18, 2023

Healthcare IT Today - (Saturday February 18, 2023)
Daily Reads/ Healthcare IT Today

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week.
6 Organizations Approved As Initial QHINs Under TEFCA. CommonWell, eHealth Exchange, Epic, Health Gorilla, Kno2, and KONZA were named the inaugural QHINs. The announcement wasn’t much of a surprise, but John said it will be interesting to see which technology vendors ultimately get behind which QHINs. Read more…
Exploring LG’s Partnership With Amwell. LG…

What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions

MedCity News - (Saturday February 18, 2023)
Frequent Updates/ MedCity News

Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for the team were covered by Abarca. However, company officials had no input in editorial coverage. 
The U.S. healthcare systems spent a whopping $301 billion on specialty drugs in 2021, a 43% increase since 2016. These specialty drugs accounted for half of the year’s total drug spending, and the list prices for specialty…

Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy

MedCity News - (Saturday February 18, 2023)
Frequent Updates/ MedCity News

Geographic atrophy, an eye disorder that starts as a loss of central vision and progressively worsens to total blindness, now has its first treatment. The FDA on Friday approved an Apellis Pharmaceuticals drug that slows the progression of this disease, which affects more than 1 million people in the U.S.
Approval of the Apellis drug, pegcetacoplan, covers all patients with geographic atrophy, a broad label that reflects the representative patient population tested in pivotal studies, Chief Medical Officer Caroline Baumal said during a Friday evening conference call. The Waltham, Massachusetts-based company plans to launch the drug in March, marketing the product under…

PBMs Come Under Fire During Senate Hearing

MedCity News - (Saturday February 18, 2023)
Frequent Updates/ MedCity News

Pharmacy Benefit Managers (PBMs) took a hit from lawmakers during a Thursday hearing held by the Senate Commerce Committee, with some questioning why the drug middlemen are even necessary.
“The way I see the situation on PBMs, I don’t know why the hell they even exist,” said Sen. Jon Tester, D-Montana. “They were set up with all the right reasons … But what I see them doing in my state, I don’t think the consumer gets much benefit and they’re shutting down small businesses on main street right and left and those are called our local neighborhood pharmacies.” The hearing discussed how…

Are You Ready for HIMSS23?

HIMSS - (Saturday February 18, 2023)
HIMSS/ Videos

Be part of the most exciting week in healthcare at #HIMSS23 in Chicago!HIMSS23 is the can’t-miss health information and technology event of the year, where professionals connect for education, innovation and collaboration.Are you ready?Join us April 17-21, 2023: https://bit.ly/3ke9rip…

Decline of Telehealth During the Pandemic and After

MedCity News - (Saturday February 18, 2023)
Frequent Updates/ MedCity News

The pandemic has forced healthcare organizations to rely heavily on telehealth services. In 2020, virtual visits accounted for more than a quarter of all outpatient visits in the U.S., and they’ve been steadily increasing since then. But there is a flip side to this trend. Recent data shows that telehealth is declining in healthcare, which could create a burden for both healthcare systems and patients. Let’s take a look at why this is happening and what can be done about it.
Reasons behind the decline  There are several factors driving the decline in telehealth utilization in healthcare settings. One reason is cost…

Fatty Liver Disease in Children: Prevalence, Evaluation, & Essential Tools

eHealth Radio Network - (Friday February 17, 2023)
eHealth Radio Network/ Podcasts

Dr. Alisha Mavis, a Pediatric Hepatologist at Duke University where she cares for pediatric patients with liver disease joins eHealth Radio and the Children’s Health & Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Alisha Mavis discuss the following:
What is the prevalence of fatty liver disease in children, and who should we be screening?
When screening a child for fatty liver disease, what are some of the tools used to evaluate for the disease, and how is the diagnosis of pediatric fatty liver disease made?
What is the natural history of pediatric liver disease, and how does this…

Q&A: Thrive Center’s CEO Makes Staffing Shortage Concerns a Top Priority

HealthTech Magazine - (Friday February 17, 2023)
AI/ Frequent Updates/ HealthTech Magazine

HEALTHTECH: What are the highest-priority issues for senior care organizations in 2023?ROSE: I think it would be workforce and staffing issues, especially in the post-acute area. Unfortunately, because of the COVID-19 pandemic, we saw so many people leave healthcare. Staffing has always been an issue, but it reached critical status during the pandemic. Now, organizations are really trying to recover, so they’re looking for solutions that can augment their workforce and make workflows seamless — not a lot of logins, not a lot of devices, more cloud-based solutions that will really drive efficiency and mobility, because that’s going to be key to a…


I am an experienced healthcare executive with over 15 years of deep clinical and informatics expertise in the design, development, implementation and support of complex healthcare solutions. Beginning my career as a cardiologist, I understand the needs of clinicians and the nature of their work.